The Changing Economics of Medical Technology

Questions? Call 800-624-6242

About | Ordering | New

LoginRegister

| Items in cart [0]

HARDBACK
price:$27.95
add to cart

Rights & Permissions

Free PDF Access

Free Resources

Related Titles

The Changing Economics of Medical Technology (1991)
Institute of Medicine (IOM)

Citation Manager Export the bibliographic data for this book in your chosen format
Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web.
Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book.
Reference Finder Paste in your own text to find books that relate to your topic.

Citation Manager

. "Appendix B: The Economics of Pharmaceutical Research and Development: An Industry Persepective." The Changing Economics of Medical Technology. Washington, DC: The National Academies Press, 1991.

Please select a format:

Page
191


E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

The Changing Economics of Medical Technology

2. According to the Pharmaceutical Manufacturers Association New Product Survey, of the 1,217 new single chemical entity drugs introduced to the U.S. market between 1940 and 1988, nearly 62 percent were discovered in the United States. Switzerland ranked second with 7 percent.

REFERENCES

1. Grabowski H. The changing economics of pharmaceutical research and development . In this volume . Washington, D.C. : National Academy Press , 1991 .

2. Teitelman R , Siwolop S , Baldo A. Global report on pharmaceuticals . Financial World 1989 ; 158: 53-80 .

3. Pharmaceutical Manufacturers Association . PMA Statistical Fact Book . Washington, D.C. : Pharmaceutical Manufacturers Association, 1989 .

4. Pharmaceutical Manufacturers Association . 1989 Annual Report . Washington, DC : Pharmaceutical Manufacturers Association , 1989 .

5. Merck & Co., Inc . 1989 Annual Report . Rahway : Merck & Co., Inc. , 1990 .

6. Veverka MJ. Pharmaceuticals . New York , Booz Allen & Hamilton , 1989 .

7. Patent Departments , Merck & Co., Inc. , and Hoffman-La Roche . Unpublished study of 77 human and animal health products approved from September 1984 through 1989 .

8. Worldwide pharma R&D trends . Scrip 1989 ; 1471 : 25 .

9. Narin F , Davidson FJ. The growth of Japanese science and technology . Science 1989 ; 245 : 600-606 .

10. Pharmaceutical Manufacturers Association . Industry Perspective: Drug Prices . Washington, D.C. : Pharmaceutical Manufacturers Association , 1989 .

11. Gannes S. The good news about U.S. R&D . Fortune 1988 ; 117 : 48-56 .

12. Science Foundation , 1988 . National Science Foundation . NSF Fact Book . Washington, D.C. : National Science Foundation

13. National, Science and Engineering Education Studies Group . Selected data on graduate science engineering students and postdoctorates by citizenship . Washington, D.C. : National Science Foundation, 1987 .

14. U.S. Bureau of the Census . Statistical Abstract of the United States: 1989 . Washington, D.C. : U.S. Government Printing Office , 1989 .

15. Truschke EF. Expand support for medical research and development . In : Alzheimer's Medicines . Washington, D.C. : Pharmaceutical Manufacturers Association , 1989 .